Travere insider plans sale of 195,841 shares

Rule 144 notice covers a planned sale of 195,841 Travere Therapeutics common shares from option exercises, following a prior 95,666-share 10b5-1 sale.

Rhea-AI Filing Summary

Travere Therapeutics, Inc. (TVTX) is the issuer for a planned sale of its common stock reported on behalf of Eric Dube under Rule 144. The notice covers the potential sale of 195,841 shares of common stock on September 16, 2026, in connection with an exercise of stock options for cash.

The securities are held through Morgan Stanley Smith Barney LLC Executive Financial Services and are listed on NASDAQ. Over the prior three months, a separate Rule 10b5-1 transaction on September 15, 2026 involved 95,666 shares of common stock at an aggregate sale price of $5,955,801.63.

Key Figures

Shares to be sold under Rule 144: 195,841 shares Recent 10b5-1 sale shares: 95,666 shares Aggregate sale price of recent 10b5-1 transaction: $5,955,801.63 +1 more

4 metrics

Shares to be sold under Rule 144 195,841 shares Travere Therapeutics common stock, with transaction date of September 16, 2026

Recent 10b5-1 sale shares 95,666 shares Common stock sale dated September 15, 2026

Aggregate sale price of recent 10b5-1 transaction $5,955,801.63 Sale of 95,666 shares of common stock on September 15, 2026

Shares outstanding reference 94,261,082 shares Common stock figure shown with the Rule 144 securities information

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options, Issuer, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for ERIC DUBE500 WALNUT ST"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 09/16/2026 | Exercise of Stock Options | Issuer"

Issuer regulatory

"Common | 09/16/2026 | Exercise of Stock Options | Issuer"

Common financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Travere Therapeutics (TVTX) disclose in this Form 144?

The filing reports a planned Rule 144 sale of 195,841 shares of Travere Therapeutics common stock on September 16, 2026, for the account of Eric Dube, with the shares to be issued upon the exercise of stock options for cash.

How many Travere Therapeutics (TVTX) shares has Eric Dube sold recently?

Over the prior three months, a Rule 10b5-1 transaction dated September 15, 2026 involved the sale of 95,666 shares of Travere Therapeutics common stock for an aggregate sale price of $5,955,801.63.

What is the size of the planned Travere Therapeutics (TVTX) share sale under Rule 144?

The notice covers a proposed sale of 195,841 shares of Travere Therapeutics common stock associated with an exercise of stock options, with the transaction date shown as September 16, 2026.

On which market are the Travere Therapeutics (TVTX) shares in this Form 144 listed?

The common stock referenced in the Form 144 for Travere Therapeutics (TVTX) is listed on NASDAQ, as indicated in the securities information section.

Who is the person for whose account the Travere Therapeutics (TVTX) shares are to be sold?

The shares are to be sold for the account of Eric Dube, as identified in the Form 144 section for the person for whose account the securities are to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:31 PM Accepted by SEC EDGAR 09/16/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001763494
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS INC
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive, Suite 300 San Diego CALIFORNIA 92130
Phone	8889697879
Name of Person for Whose Account the Securities are To Be Sold	ERIC DUBE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	195841	12242020.91	94261082	09/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2026	Exercise of Stock Options	Issuer			195841	09/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERIC DUBE500 WALNUT ST 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	09/15/2026	95666	5955801.63

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eric Dube
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)